AMBER ERWIN: Open Payments
NPI 1417107855 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,618 in 157 payments from 24 companies in 2025. Trend: 2023 $3,160 · 2024 $3,523 · 2025 $3,618
Food & beverage: $3,618
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 34 | $656 |
| AstraZeneca Pharmaceuticals LP | 14 | $604 |
| GENZYME CORPORATION | 13 | $516 |
| Insmed, Inc. | 11 | $245 |
| Amgen Inc. | 14 | $203 |
| Verona Pharma, Inc. | 7 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $159 |
| Inspire Medical Systems, Inc. | 12 | $137 |
| Mallinckrodt Hospital Products Inc. | 4 | $128 |
| Paratek Pharmaceuticals, Inc. | 5 | $115 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, TRELEGY ELLIPTA, Arikayce, TEZSPIRE, FASENRA, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
